Intranasal Dexmedetomidine and Perioperative Myocardial Injury
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.
Also called NCT07549282
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 140 participants
- Registry
-
NCT07549282
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07549282. Randomized; quadruple masking; primary purpose prevention. Start 2026-08 (anticipated); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intranasal Dexmedetomidine and Perioperative Myocardial Injury
- Condition
- Coronary Heart Disease
- Condition
- Myocardial Injury
- Condition
- Myocardial Infarction
- Condition
- Dexmedetomidine
- Intervention (Drug)
- Intranasal Dexmedetomidine
- Intervention (Drug)
- Normal saline
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct07549282- Content hash
bf62ade2ff2b98b98bb6f69ce8df48ce3760cf256fd8d259f15abc7f52e271a2